Expression of regulatory tĝ€"cell-related molecule genes and clinical outcome in kidney transplant recipients

Transplantation

Volumn 87, Issue 6, 2009, Pages 857-863

  Alvarez, Cristiam M ^a,b   Opelz, Gerhard ^b   Garcia, Luis F ^a   Süsal, Caner ^b  

^a UNIVERSIDAD DE ANTIOQUIA   (Colombia)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Gene expression; Kidney transplantation; Long term graft survival; Regulatory T cells; Transplantation tolerance

Indexed keywords

AZATHIOPRINE; CALCINEURIN INHIBITOR; CHEMOKINE RECEPTOR CCR7; CHEMOKINE RECEPTOR CXCR4; COMPLEMENTARY DNA; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GLUCOCORTICOID INDUCED TUMOR NECROSIS FACTOR RECEPTOR; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PROTEIN; RNA; STEROID; TACROLIMUS; TRANSCRIPTION FACTOR FOXP3; TRANSCRIPTION FACTOR GATA 3; TRANSCRIPTION FACTOR T BET; TRANSFORMING GROWTH FACTOR BETA; TRIBBLES PROTEIN 1; UNCLASSIFIED DRUG; CHEMOKINE RECEPTOR CXCR; CXCR4 PROTEIN, HUMAN; CXCR7 PROTEIN, HUMAN; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GRAFT SURVIVAL; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MALE; ORGAN TRANSPLANTATION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RECEPTOR GENE; REGULATORY T LYMPHOCYTE; TREATMENT OUTCOME; ALLOTRANSPLANTATION; CHRONIC KIDNEY FAILURE; GENETIC TRANSCRIPTION; GENETICS; IMMUNOLOGY; MIDDLE AGED; PHYSIOLOGY; REFERENCE VALUE; RENAL REPLACEMENT THERAPY;

ADULT; AGED; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; GRAFT SURVIVAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; POSTOPERATIVE PERIOD; RECEPTORS, CXCR; RECEPTORS, CXCR4; REFERENCE VALUES; RENAL DIALYSIS; T-LYMPHOCYTES, REGULATORY; TRANSCRIPTION, GENETIC; TRANSFORMING GROWTH FACTOR BETA; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 65549149538     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e318199fa57     Document Type: Article

References (38)

1. Sykes M. Immune tolerance: Mechanisms and application in clinical transplantation. J Intern Med 2007; 262: 288.
2. Salama AD, Womer KL, Sayegh MH. Clinical transplantation tolerance: Many rivers to cross. J Immunol 2007; 178: 5419.
3. Long E, Wood KJ. Understanding FOXP3: Progress towards achieving transplantation tolerance. Transplantation 2007; 84: 459.
4. Ziegler SF. FOXP3: Of mice and men. Annu Rev Immunol 2006; 24: 209.
5. Zheng Y, Josefowicz SZ, Kas A, et al. Genome-wide analysis of Foxp3 target genes in developing and mature regulatory T cells. Nature 2007; 445: 936.
6. Bacchetta R, Gambineri E, Roncarolo MG. Role of regulatory T cells and FOXP3 in human diseases. J Allergy Clin Immunol 2007; 120: 227.
7. Belkaid Y. Regulatory T cells and infection: A dangerous necessity. Nat Rev Immunol 2007; 7: 875.
8. Wan YY, Flavell RA. Regulatory T cells, transforming growth factorbeta, and immune suppression. Proc Am Thorac Soc 2007; 4: 271.
9. Schneider MA, Meingassner JG, Lipp M, et al. CCR7 is required for the in vivo function of CD4 CD25 regulatory T cells. J Exp Med 2007; 204: 735.
10. Ueha S, Yoneyama H, Hontsu S, et al. CCR7 mediates the migration of Foxp3 regulatory T cells to the paracortical areas of peripheral lymph nodes through high endothelial venules. J Leukoc Biol 2007; 82: 1230.
11. Menning A, Hopken UE, Siegmund K, et al. Distinctive role of CCR7 in migration and functional activity of naive- and effector/memory-like Treg subsets. Eur J Immunol 2007; 37: 1575.
12. Garrod KR, Chang CK, Liu FC, et al. Targeted lymphoid homing of dendritic cells is required for prolongation of allograft survival. J Immunol 2006; 177: 863.
13. Tosello V, Odunsi K, Souleimanian NE, et al. Differential expression of CCR7 defines two distinct subsets of human memory CD4-CD25- Tregs. Clin Immunol 2008; 126: 291.
14. Zou L, Barnett B, Safah H, et al. Bone marrow is a reservoir for CD4-CD25- regulatory T cells that traffic through CXCL12/CXCR4 signals. Cancer Res 2004; 64: 8451.
15. Alvarez CM, Opelz G, Giraldo MC, et al. Evaluation of T-cell receptor repertoires in patients with long-term renal allograft survival. Am J Transplant 2005; 5: 746.
16. Alvarez CM, Paris SC, Arango L, et al. Kidney transplant patients with long-term graft survival have altered expression of molecules associated with T-cell activation. Transplantation 2004; 78: 1541.
17. Nikolova PN, Ivanova MI, Mihailova SM, et al. Cytokine gene polymorphism in kidney transplantation-Impact of TGF-beta 1, TNFalpha and IL-6 on graft outcome. Transpl Immunol 2008; 18: 344.
18. Harris S, Coupes BM, Roberts SA, et al. TGF-beta1 in chronic allograft nephropathy following renal transplantation. J Nephrol 2007; 20: 177.
19. Kasprowicz DJ, Smallwood PS, Tyznik AJ, et al. Scurfin (FoxP3) controls T-dependent immune responses in vivo through regulation of CD4- T cell effector function. J Immunol 2003; 171: 1216.
20. Louis S, Braudeau C, Giral M, et al. Contrasting CD25hiCD4-T cells/ FOXP3 patterns in chronic rejection and operational drug-free tolerance. Transplantation 2006; 81: 398.
21. Baecher-Allan C, Viglietta V, Hafler DA. Human CD4-CD25- regulatory T cells. Semin Immunol 2004; 16: 89.
22. Yong Z, Chang L, Mei YX, et al. Role and mechanisms of CD4-CD25- regulatory T cells in the induction and maintenance of transplantation tolerance. Transpl Immunol 2007; 17: 120.
23. Bharat A, Fields RC, Trulock EP, et al. Induction of IL-10 suppressors in lung transplant patients by CD4-25- regulatory T cells through CTLA-4 signaling. J Immunol 2006; 177: 5631.
24. Bushell A, Wood K. GITR ligation blocks allograft protection by induced CD25-CD4- regulatory T cells without enhancing effector Tcell function. Am J Transplant 2007; 7: 759.
25. Kingsley CI, Karim M, Bushell AR, et al. CD25-CD4- regulatory T cells prevent graft rejection: CTLA-4- and IL-10-dependent immunoregulation of alloresponses. J Immunol 2002; 168: 1080.
26. Hartigan-O'Connor DJ, Poon C, Sinclair E, et al. Human CD4- regulatory T cells express lower levels of the IL-7 receptor alpha chain (CD127), allowing consistent identification and sorting of live cells. J Immunol Methods 2007; 319: 41.
27. Kitani A, Chua K, Nakamura K, et al. Activated self-MHC reactive T cells have the cytokine phenotype of Th3/T regulatory cell 1 T cells. J Immunol 2000; 165: 691.
28. Sundrud MS, Rao A. New twists of T cell fate: Control of T cell activation and tolerance by TGF-beta and NFAT. Curr Opin Immunol 2007; 19: 287.
29. Kemeny DM, Macary PA. The growing complexity of TGF-beta as a T-cell regulator. Immunology 2005; 114: 459.
30. Feldman G, Kiely B, Martin N, et al. Role for TGF-beta in cyclosporineinduced modulation of renal epithelial barrier function. J Am Soc Nephrol 2007; 18: 1662.
31. Pascual M, Swinford RD, Ingelfinger JR, et al. Chronic rejection and chronic cyclosporin toxicity in renal allografts. Immunol Today 1998; 19: 514.
32. Kiss-Toth E, Bagstaff SM, Sung HY, et al. Human tribbles, a protein family controlling mitogen-activated protein kinase cascades. J Biol Chem 2004; 279: 42703.
33. Hegedus Z, Czibula A, Kiss-Toth E. Tribbles: A family of kinase-like proteins with potent signalling regulatory function. Cell Signal 2007; 19: 238.
34. Ashton-Chess J, Giral M, Mengel M, et al. Tribbles-1 as a novel biomarker of chronic antibody-mediated rejection. J AmSoc Nephrol 2008; 19: 1116.
35. Segundo DS, Ruiz JC, Izquierdo M, et al. Calcineurin inhibitors, but not rapamycin, reduce percentages of CD4-CD25-FOXP3- regulatory T cells in renal transplant recipients. Transplantation 2006; 82: 550.
36. Korczak-Kowalska G, Wierzbicki P, Bocian K, et al. The influence of immunosuppressive therapy on the development of CD4-CD25- T cells after renal transplantation. Transplant Proc 2007; 39: 2721.
37. Demirkiran A, Kok A, Kwekkeboom J, et al. Decrease of CD4-CD25- T cells in peripheral blood after liver transplantation: Association with immunosuppression. Transplant Proc 2005; 37: 1194.
38. Meloni F, Morosini M, Solari N, et al. Peripheral CD4- CD25- Treg cell expansion in lung transplant recipients is not affected by calcineurin inhibitors. Int Immunopharmacol 2006; 6: 2002.